MedKoo Cat#: 414146 | Name: Etymemazine free base

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Etymemazine Free Base is an antipsychotic, antihistamine and anticholinergic drug of the phenothiazine chemical class, structurally related to cyamemazine and methotrimeprazine.

Chemical Structure

 Etymemazine free base
Etymemazine free base
CAS#523-54-6 (free base)

Theoretical Analysis

MedKoo Cat#: 414146

Name: Etymemazine free base

CAS#: 523-54-6 (free base)

Chemical Formula: C20H26N2S

Exact Mass: 326.1817

Molecular Weight: 326.50

Elemental Analysis: C, 73.57; H, 8.03; N, 8.58; S, 9.82

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Etymemazine free base; Ethylisobutrazine; Ethotrimeprazine; Etimemazina; Ethyl isobutrazine; NSC169471; NSC 169471; NSC-169471
IUPAC/Chemical Name
3-(2-ethyl-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine
InChi Key
USKHCLAXJXCWMO-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H26N2S/c1-5-16-10-11-20-18(12-16)22(14-15(2)13-21(3)4)17-8-6-7-9-19(17)23-20/h6-12,15H,5,13-14H2,1-4H3
SMILES Code
CC(CN1C2=C(C=CC=C2)SC3=CC=C(CC)C=C13)CN(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 326.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ahmed M, Adil M, Haq IU, Tipu MK, Qasim M, Gul B. RP-HPLC-based phytochemical analysis and diverse pharmacological evaluation of Quercus floribunda Lindl. ex A. Camus nuts extracts. Nat Prod Res. 2019 Sep 19:1-6. doi: 10.1080/14786419.2019.1667347. Epub ahead of print. PMID: 31533474. 2: RAVINA A, TARGOWLA R. [Clinical study of a new phenothiazine derivative, RP-6484]. Presse Med. 1960 Jun 11;68:1119-21. French. PMID: 14436567. 3: RONDEPIERRE JJ, ROPERT R, AZOULAY J. [On the clinical use in neuropsychiatry of 3-ethyl-10-(2-methyl-3-dimethylaminopropyl)-phenothiazine HCl (RP-6484), new phenothiazine neuroleptic]. Presse Med. 1962 Jun 2;70:1342-4. French. PMID: 14493669. 4: TRILLOT J, NOYER J, LAMOTTE. DEMENCE PRECOCE. GUERISON PAR LE 6484 R.P [DEMENTIA PRAECOX. CURE BY RP-6484]. Toulouse Med. 1963 Dec;64:1228-30. French. PMID: 14099369. 5: PLANTE N. LE 6484 R.P., UN TRANQUILLISANT ANXIOLYTIQUE ET HYPNOTIQUE [6484 RP, AN ANXIOLYTIC AND HYPNOTIC TRANQUILIZER]. Laval Med. 1963 Oct;34:969-73. French. PMID: 14094402. 6: Changotra A, Bhaskararao B, Hadad CM, Sunoj RB. Insights on Absolute and Relative Stereocontrol in Stereodivergent Cooperative Catalysis. J Am Chem Soc. 2020 May 27;142(21):9612-9624. doi: 10.1021/jacs.9b13962. Epub 2020 May 18. PMID: 32370493. 7: Tian Y, Liang H, Dobrynin AV. Elastocapillarity and rolling dynamics of solid nanoparticles on soft elastic substrates. Soft Matter. 2020 Mar 4;16(9):2230-2237. doi: 10.1039/c9sm02280e. PMID: 31998920. 8: Corrêa ASM, Lamarão LM, Vieira PCM, de Castro RBH, de Almeida NCC, de Castro JAA, de Lima MSM, Palmeira MK, Meireles ALLP, Burbano RR. Prevalence, incidence and residual risk of transfusion-transmitted HBV infection before and after the implementation of HBV-NAT in northern Brazil. PLoS One. 2018 Dec 19;13(12):e0208414. doi: 10.1371/journal.pone.0208414. PMID: 30566494; PMCID: PMC6300202. 9: Gruppen EG, Garcia E, Connelly MA, Jeyarajah EJ, Otvos JD, Bakker SJL, Dullaart RPF. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function. Sci Rep. 2017 Oct 23;7(1):13781. doi: 10.1038/s41598-017-13739-9. PMID: 29061990; PMCID: PMC5653802.